1. Home
  2. LTRN vs NMTC Comparison

LTRN vs NMTC Comparison

Compare LTRN & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$0.29

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

N/A

Current Price

$0.68

Market Cap

8.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LTRN
NMTC
Founded
2013
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
8.1M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
LTRN
NMTC
Price
$0.29
$0.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
★ $17.50
$7.27
AVG Volume (30 Days)
★ 166.9K
45.6K
Earning Date
11-17-2026
12-16-2026
Dividend Yield
N/A
N/A
EPS Growth
18.65
★ 80.43
EPS
N/A
★ N/A
Revenue
N/A
★ $9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 163.47
52 Week Low
$0.36
$0.61
52 Week High
$4.34
$12.24

Technical Indicators

Market Signals
Indicator
LTRN
NMTC
Relative Strength Index (RSI) 20.94 32.81
Support Level N/A $0.61
Resistance Level $0.84 $1.35
Average True Range (ATR) 0.08 0.10
MACD -0.00 -0.00
Stochastic Oscillator 0.07 6.94

Price Performance

Historical Comparison
LTRN
NMTC

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: